2011

1. A new-generation ultra-long-acting basal insulin with a bolus boost compared with insulin glargine in insulin-naïve people with type 2 diabetes: A randomized, controlled trial

   Diabetes Care, Vol. 34, Núm. 3, pp. 669-674